Constellation Pharmaceuticals Overview

Constellation Pharmaceuticals Operating Income

Operating Income for CNST.

Quarterly Operating Income

$-40226000.00

↑ 54.82% YoY

As of Mar 31, 2021

Annual Operating Income (TTM)

$-139090000.00

↑ 51.3% YoY

Trailing 12 months ending Mar 31, 2021

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin